Stay updated with breaking news from Nasdaq Lbph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) has received an average rating of “Buy” from the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Six analysts have rated the stock with a buy rating. The average 12-month target price among analysts that have issued a report on the stock in […]
Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) have been given a consensus recommendation of “Buy” by the six brokerages that are covering the stock, Marketbeat reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the stock […]
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) saw a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 657,800 shares, a decline of 7.9% from the July 15th total of 714,400 shares. Based on an average daily volume of 124,100 shares, the short-interest ratio […]
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Free Report) – Research analysts at Cantor Fitzgerald lowered their FY2023 earnings per share estimates for shares of Longboard Pharmaceuticals in a research note issued to investors on Monday, August 7th. Cantor Fitzgerald analyst C. Duncan now anticipates that the company will earn ($2.33) per share for the year, down […]
Longboard Pharmaceuticals (NASDAQ:LBPH – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research report issued to clients and investors on Monday, Benzinga reports. They presently have a $25.00 price objective on the stock. HC Wainwright’s price objective would indicate a potential upside of 264.43% from the […]